Abstract
PHYSICIANS are often faced with the serious problem of intractable pain in patients with metastatic carcinoma of the prostate. The hormonal treatment, either by orchiectomy or external estrogens, is the most widely used therapy for inoperable carcinoma of the prostate since the discovery of endocrine influence on prostatic cancer by Huggins<sup>1</sup>in 1941. However, some patients, after a period of symptomatic relief, fail to respond to the conservative therapy of castration and estrogens used alone or in combination. External radiation, bilateral adrenalectomy, hypophysectomy, and chordotomy have been used to relieve the incapacitating pain. The studies made by Lawrence and Tobins,<sup>2</sup>who used radioactive phosphorus on neoplastic tissues, stimulated interest in this method of therapy as a possible means of improving palliation in advanced malignancy. In recent years,<sup>32</sup>P has received increased recognition for palliation in these cases, particularly where bony metastases are present.<sup>3-5</sup>In this series,
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
